{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:40:55Z","timestamp":1794487255027,"version":"4.9.1"},"reference-count":264,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41579-026-01327-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:57:20Z","timestamp":1781175440000},"page":"685-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms of HIV-1 assembly, release and maturation"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-1345","authenticated-orcid":false,"given":"Alex B.","family":"Kleinpeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-022X","authenticated-orcid":false,"given":"Eric O.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00048-22","volume":"87","author":"S Jang","year":"2023","unstructured":"Jang, S. & Engelman, A. N. Capsid\u2013host interactions for HIV-1 ingress. Microbiol. Mol. Biol. Rev. 87, e0004822 (2023).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1327_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrmicro3490","volume":"13","author":"EO Freed","year":"2015","unstructured":"Freed, E. O. HIV-1 assembly, release and maturation. Nat. Rev. Microbiol. 13, 484\u2013496 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"1327_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/jmbi.1994.1719","volume":"244","author":"MA Massiah","year":"1994","unstructured":"Massiah, M. A. et al. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244, 198\u2013223 (1994).","journal-title":"J. Mol. Biol."},{"key":"1327_CR4","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1073\/pnas.93.7.3099","volume":"93","author":"CP Hill","year":"1996","unstructured":"Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M. & Sundquist, W. I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA 93, 3099\u20133104 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR5","doi-asserted-by":"publisher","first-page":"E182","DOI":"10.1073\/pnas.1516618113","volume":"113","author":"PR Tedbury","year":"2016","unstructured":"Tedbury, P. R., Novikova, M., Ablan, S. D. & Freed, E. O. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation. Proc. Natl Acad. Sci. USA 113, E182\u2013E190 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR6","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/emboj\/17.9.2699","volume":"17","author":"H Reil","year":"1998","unstructured":"Reil, H., Bukovsky, A. A., Gelderblom, H. R. & G\u00f6ttlinger, H. G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699\u20132708 (1998).","journal-title":"EMBO J."},{"key":"1327_CR7","doi-asserted-by":"publisher","first-page":"e01079-19","DOI":"10.1128\/JVI.01079-19","volume":"93","author":"A Alfadhli","year":"2019","unstructured":"Alfadhli, A. et al. Analysis of HIV-1 matrix\u2013envelope cytoplasmic tail interactions. J. Virol. 93, e01079-19 (2019).","journal-title":"J. Virol."},{"key":"1327_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.virol.2009.02.048","volume":"387","author":"A Alfadhli","year":"2009","unstructured":"Alfadhli, A., Barklis, R. L. & Barklis, E. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 387, 466\u2013472 (2009).","journal-title":"Virology"},{"key":"1327_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.abe6821","volume":"373","author":"K Qu","year":"2021","unstructured":"Qu, K. et al. Maturation of the matrix and viral membrane of HIV-1. Science 373, 700\u2013704 (2021).","journal-title":"Science"},{"key":"1327_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-025-08624-9","volume":"640","author":"JCV Stacey","year":"2025","unstructured":"Stacey, J. C. V. et al. The conserved HIV-1 spacer peptide 2 triggers matrix lattice maturation. Nature 640, 258\u2013264 (2025).","journal-title":"Nature"},{"key":"1327_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.273.5272.231","volume":"273","author":"RK Gitti","year":"1996","unstructured":"Gitti, R. K. et al. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273, 231\u2013235 (1996).","journal-title":"Science"},{"key":"1327_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1126\/science.278.5339.849","volume":"278","author":"TR Gamble","year":"1997","unstructured":"Gamble, T. R. et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278, 849\u2013853 (1997).","journal-title":"Science"},{"key":"1327_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0092-8674(00)81823-1","volume":"87","author":"TR Gamble","year":"1996","unstructured":"Gamble, T. R. et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285\u20131294 (1996).","journal-title":"Cell"},{"key":"1327_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2007.08.018","volume":"131","author":"BK Ganser-Pornillos","year":"2007","unstructured":"Ganser-Pornillos, B. K., Cheng, A. & Yeager, M. Structure of Full-Length HIV-1 CA: a model for the mature capsid lattice. Cell 131, 70\u201379 (2007).","journal-title":"Cell"},{"key":"1327_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/v13030417","volume":"13","author":"S Zhuang","year":"2021","unstructured":"Zhuang, S. & Torbett, B. E. Interactions of HIV-1 capsid with host factors and their implications for developing novel therapeutics. Viruses 13, 417 (2021).","journal-title":"Viruses"},{"key":"1327_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.crstbi.2020.10.002","volume":"2","author":"J Temple","year":"2020","unstructured":"Temple, J., Tripler, T. N., Shen, Q. & Xiong, Y. A snapshot of HIV-1 capsid\u2013host interactions. Curr. Res. Struct. Biol. 2, 222\u2013228 (2020).","journal-title":"Curr. Res. Struct. Biol."},{"key":"1327_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00583-z","volume":"18","author":"WM McFadden","year":"2021","unstructured":"McFadden, W. M. et al. Rotten to the core: antivirals targeting the HIV-1 capsid core. Retrovirology 18, 41 (2021).","journal-title":"Retrovirology"},{"key":"1327_CR18","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/emboj\/17.6.1555","volume":"17","author":"UK von Schwedler","year":"1998","unstructured":"von Schwedler, U. K. et al. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17, 1555\u20131568 (1998).","journal-title":"EMBO J."},{"key":"1327_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/pro.5560010502","volume":"1","author":"MF Summers","year":"1992","unstructured":"Summers, M. F. et al. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1, 563\u2013574 (1992).","journal-title":"Protein Sci."},{"key":"1327_CR20","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1128\/jvi.64.5.1920-1926.1990","volume":"64","author":"A Aldovini","year":"1990","unstructured":"Aldovini, A. & Young, R. A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64, 1920\u20131926 (1990).","journal-title":"J. Virol."},{"key":"1327_CR21","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1128\/jvi.64.7.3207-3211.1990","volume":"64","author":"RJ Gorelick","year":"1990","unstructured":"Gorelick, R. J. et al. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64, 3207\u20133211 (1990).","journal-title":"J. Virol."},{"key":"1327_CR22","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1128\/JVI.74.7.3046-3057.2000","volume":"74","author":"A Cimarelli","year":"2000","unstructured":"Cimarelli, A., Sandin, S., H\u00f6glund, S. & Luban, J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74, 3046\u20133057 (2000).","journal-title":"J. Virol."},{"key":"1327_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/v16030420","volume":"16","author":"CA Vanegas-Torres","year":"2024","unstructured":"Vanegas-Torres, C. A. & Schindler, M. HIV-1 Vpr functions in primary CD4+ T Cells. Viruses 16, 420 (2024).","journal-title":"Viruses"},{"key":"1327_CR24","doi-asserted-by":"publisher","first-page":"14889","DOI":"10.1073\/pnas.0405596101","volume":"101","author":"A Ono","year":"2004","unstructured":"Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K. & Freed, E. O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA 101, 14889\u201314894 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR25","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1128\/JVI.01614-07","volume":"82","author":"V Chukkapalli","year":"2008","unstructured":"Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W. S. & Ono, A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 82, 2405\u20132417 (2008).","journal-title":"J. Virol."},{"key":"1327_CR26","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/pnas.0602818103","volume":"103","author":"JS Saad","year":"2006","unstructured":"Saad, J. S. et al. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA 103, 11364\u201311369 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.25287","volume":"6","author":"F M\u00fccksch","year":"2017","unstructured":"M\u00fccksch, F., Laketa, V., M\u00fcller, B., Schultz, C. & Kr\u00e4usslich, H.-G. Synchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring. eLife 6, e25287 (2017).","journal-title":"eLife"},{"key":"1327_CR28","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1128\/jvi.70.12.8540-8548.1996","volume":"70","author":"W Zhou","year":"1996","unstructured":"Zhou, W. & Resh, M. D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70, 8540\u20138548 (1996).","journal-title":"J. Virol."},{"key":"1327_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1073\/pnas.0305665101","volume":"101","author":"C Tang","year":"2004","unstructured":"Tang, C. et al. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA 101, 517\u2013522 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14663","volume":"5","author":"LA Carlson","year":"2016","unstructured":"Carlson, L. A., Bai, Y., Keane, S. C., Doudna, J. A. & Hurley, J. H. Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies. eLife 5, e14663 (2016).","journal-title":"eLife"},{"key":"1327_CR31","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.jmb.2018.04.042","volume":"430","author":"CR Gaines","year":"2018","unstructured":"Gaines, C. R. et al. HIV-1 matrix protein interactions with tRNA: implications for membrane targeting. J. Mol. Biol. 430, 2113\u20132127 (2018).","journal-title":"J. Mol. Biol."},{"key":"1327_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cell.2014.09.057","volume":"159","author":"SB Kutluay","year":"2014","unstructured":"Kutluay, S. B. et al. Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis. Cell 159, 1096\u20131109 (2014).","journal-title":"Cell"},{"key":"1327_CR33","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1128\/JVI.01197-09","volume":"83","author":"A Alfadhli","year":"2009","unstructured":"Alfadhli, A., Still, A. & Barklis, E. Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J. Virol. 83, 12196\u201312203 (2009).","journal-title":"J. Virol."},{"key":"1327_CR34","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1073\/pnas.0908661107","volume":"107","author":"V Chukkapalli","year":"2010","unstructured":"Chukkapalli, V., Oh, S. J. & Ono, A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl Acad. Sci. USA 107, 1600\u20131605 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR35","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1128\/JVI.74.7.3264-3272.2000","volume":"74","author":"DH Nguyen","year":"2000","unstructured":"Nguyen, D. H. & Hildreth, J. E. K. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264\u20133272 (2000).","journal-title":"J. Virol."},{"key":"1327_CR36","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1073\/pnas.241320298","volume":"98","author":"A Ono","year":"2001","unstructured":"Ono, A. & Freed, E. O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA 98, 13925\u201313930 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR37","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1073\/pnas.0511136103","volume":"103","author":"B Br\u00fcgger","year":"2006","unstructured":"Br\u00fcgger, B. et al. The HIV lipidome: a raft with an unusual composition. Proc. Natl Acad. Sci. USA 103, 2641\u20132646 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53939-z","volume":"9","author":"F M\u00fccksch","year":"2019","unstructured":"M\u00fccksch, F. et al. Quantification of phosphoinositides reveals strong enrichment of PIP(2) in HIV-1 compared to producer cell membranes. Sci. Rep. 9, 17661 (2019).","journal-title":"Sci. Rep."},{"key":"1327_CR39","doi-asserted-by":"publisher","first-page":"11228","DOI":"10.1128\/JVI.00981-08","volume":"82","author":"R Chan","year":"2008","unstructured":"Chan, R. et al. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82, 11228\u201311238 (2008).","journal-title":"J. Virol."},{"key":"1327_CR40","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.1128\/JVI.00743-11","volume":"85","author":"IB Hogue","year":"2011","unstructured":"Hogue, I. B., Grover, J. R., Soheilian, F., Nagashima, K. & Ono, A. Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. J. Virol. 85, 9749\u20139766 (2011).","journal-title":"J. Virol."},{"key":"1327_CR41","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1016\/j.jmb.2020.07.018","volume":"432","author":"Y Wen","year":"2020","unstructured":"Wen, Y., Feigenson, G. W., Vogt, V. M. & Dick, R. A. Mechanisms of PI(4,5)P2 enrichment in HIV-1 viral membranes. J. Mol. Biol. 432, 5343\u20135364 (2020).","journal-title":"J. Mol. Biol."},{"key":"1327_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep39332","volume":"6","author":"N Yandrapalli","year":"2016","unstructured":"Yandrapalli, N. et al. Self assembly of HIV-1 Gag protein on lipid membranes generates PI(4,5)P(2)\/cholesterol nanoclusters. Sci. Rep. 6, 39332 (2016).","journal-title":"Sci. Rep."},{"key":"1327_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw8651","volume":"5","author":"C Favard","year":"2019","unstructured":"Favard, C. et al. HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly. Sci. Adv. 5, eaaw8651 (2019).","journal-title":"Sci. Adv."},{"key":"1327_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42994-w","volume":"14","author":"N Tomishige","year":"2023","unstructured":"Tomishige, N. et al. HIV-1 Gag targeting to the plasma membrane reorganizes sphingomyelin-rich and cholesterol-rich lipid domains. Nat. Commun. 14, 7353 (2023).","journal-title":"Nat. Commun."},{"key":"1327_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41556-019-0300-y","volume":"21","author":"P Sengupta","year":"2019","unstructured":"Sengupta, P. et al. A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles. Nat. Cell Biol. 21, 452\u2013461 (2019).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR46","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/jvi.62.8.2578-2586.1988","volume":"62","author":"JM Orenstein","year":"1988","unstructured":"Orenstein, J. M., Meltzer, M. S., Phipps, T. & Gendelman, H. E. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J. Virol. 62, 2578\u20132586 (1988).","journal-title":"J. Virol."},{"key":"1327_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1034\/j.1600-0854.2002.31004.x","volume":"3","author":"G Raposo","year":"2002","unstructured":"Raposo, G. et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718\u2013729 (2002).","journal-title":"Traffic"},{"key":"1327_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1083\/jcb.200609050","volume":"177","author":"M Deneka","year":"2007","unstructured":"Deneka, M., Pelchen-Matthews, A., Byland, R., Ruiz-Mateos, E. & Marsh, M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177, 329\u2013341 (2007).","journal-title":"J. Cell Biol."},{"key":"1327_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030036","volume":"3","author":"S Welsch","year":"2007","unstructured":"Welsch, S. et al. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36 (2007).","journal-title":"PLoS Pathog."},{"key":"1327_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000015","volume":"4","author":"K Gousset","year":"2008","unstructured":"Gousset, K. et al. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 4, e1000015 (2008).","journal-title":"PLoS Pathog."},{"key":"1327_CR51","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1128\/JVI.00834-11","volume":"85","author":"S Welsch","year":"2011","unstructured":"Welsch, S., Groot, F., Kr\u00e4usslich, H.-G., Keppler, O. T. & Sattentau, Q. J. Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J. Virol. 85, 7922\u20137927 (2011).","journal-title":"J. Virol."},{"key":"1327_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/342714a0","volume":"342","author":"ML Zapp","year":"1989","unstructured":"Zapp, M. L. & Green, M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342, 714\u2013716 (1989).","journal-title":"Nature"},{"key":"1327_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1242\/jcs.00268","volume":"116","author":"BR Cullen","year":"2003","unstructured":"Cullen, B. R. Nuclear RNA export. J. Cell Sci. 116, 587\u2013597 (2003).","journal-title":"J. Cell Sci."},{"key":"1327_CR54","doi-asserted-by":"publisher","first-page":"13535","DOI":"10.1073\/pnas.0906822106","volume":"106","author":"J Chen","year":"2009","unstructured":"Chen, J. et al. High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc. Natl Acad. Sci. USA 106, 13535\u201313540 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003249","volume":"9","author":"OA Nikolaitchik","year":"2013","unstructured":"Nikolaitchik, O. A. et al. Dimeric RNA recognition regulates HIV-1 genome packaging. PLoS Pathog. 9, e1003249 (2013).","journal-title":"PLoS Pathog."},{"key":"1327_CR56","doi-asserted-by":"publisher","first-page":"a006882","DOI":"10.1101\/cshperspect.a006882","volume":"2","author":"WS Hu","year":"2012","unstructured":"Hu, W. S. & Hughes, S. H. HIV-1 reverse transcription. Cold Spring Harb. Perspect. Med. 2, a006882 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1327_CR57","doi-asserted-by":"crossref","unstructured":"Levin, J. G., Guo, J., Rouzina, I. & Musier-Forsyth, K. in Progress in Nucleic Acid Research and Molecular Biology Vol. 80 (ed. Moldave, K.) 217\u2013286 (Academic, 2005).","DOI":"10.1016\/S0079-6603(05)80006-6"},{"key":"1327_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00861-23","volume":"15","author":"A Duchon","year":"2024","unstructured":"Duchon, A. & Hu, W.-S. HIV-1 RNA genome packaging: it\u2019s G-rated. mBio 15,\u00a0e0086123 (2024).","journal-title":"mBio"},{"key":"1327_CR59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.1210460","volume":"334","author":"K Lu","year":"2011","unstructured":"Lu, K. et al. NMR detection of structures in the HIV-1 5\u2032-leader RNA that regulate genome packaging. Science 334, 242\u2013245 (2011).","journal-title":"Science"},{"key":"1327_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep17680","volume":"5","author":"T Masuda","year":"2015","unstructured":"Masuda, T. et al. Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA. Sci. Rep. 5, 17680 (2015).","journal-title":"Sci. Rep."},{"key":"1327_CR61","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1073\/pnas.1616627113","volume":"113","author":"S Kharytonchyk","year":"2016","unstructured":"Kharytonchyk, S. et al. Transcriptional start site heterogeneity modulates the structure and function of the HIV-1 genome. Proc. Natl Acad. Sci. USA 113, 13378\u201313383 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114494118","volume":"118","author":"OA Nikolaitchik","year":"2021","unstructured":"Nikolaitchik, O. A. et al. Selective packaging of HIV-1 RNA genome is guided by the stability of 5\u2019 untranslated region polyA stem. Proc. Natl Acad. Sci. USA 118, e2114494118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR63","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.aaz7959","volume":"368","author":"JD Brown","year":"2020","unstructured":"Brown, J. D. et al. Structural basis for transcriptional start site control of HIV-1 RNA fate. Science 368, 413\u2013417 (2020).","journal-title":"Science"},{"key":"1327_CR64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112475118","volume":"118","author":"P Ding","year":"2021","unstructured":"Ding, P. et al. 5\u2019-Cap sequestration is an essential determinant of HIV-1 genome packaging. Proc. Natl Acad. Sci. USA 118, e2112475118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407400121","volume":"121","author":"S Yasin","year":"2024","unstructured":"Yasin, S. et al. Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation. Proc. Natl Acad. Sci. USA 121, e2407400121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2024.102896","volume":"88","author":"K Musier-Forsyth","year":"2024","unstructured":"Musier-Forsyth, K., Rein, A. & Hu, W.-S. Transcription start site choice regulates HIV-1 RNA conformation and function. Curr. Opin. Struct. Biol. 88, 102896 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1327_CR67","doi-asserted-by":"publisher","first-page":"e02139","DOI":"10.1128\/jvi.02139-24","volume":"99","author":"K GC","year":"2025","unstructured":"GC, K. et al. HIV-1 single-transcription start-site mutants display complementary replication functions that are restored by reversion. J. Virol. 99, e02139\u201324 (2025).","journal-title":"J. Virol."},{"key":"1327_CR68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305103120","volume":"120","author":"OA Nikolaitchik","year":"2023","unstructured":"Nikolaitchik, O. A. et al. HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness. Proc. Natl Acad. Sci. USA 120, e2305103120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR69","doi-asserted-by":"publisher","first-page":"e02319","DOI":"10.1128\/JVI.02319-16","volume":"91","author":"KA Dilley","year":"2017","unstructured":"Dilley, K. A. et al. Interactions between HIV-1 Gag and viral RNA genome enhance virion assembly. J. Virol. 91, e02319-16 (2017).","journal-title":"J. Virol."},{"key":"1327_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38438","volume":"7","author":"M Comas-Garcia","year":"2018","unstructured":"Comas-Garcia, M. et al. Efficient support of virus-like particle assembly by the HIV-1 packaging signal. eLife 7, e38438 (2018).","journal-title":"eLife"},{"key":"1327_CR71","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83548","volume":"12","author":"X Lei","year":"2023","unstructured":"Lei, X., Gon\u00e7alves-Carneiro, D., Zang, T. M. & Bieniasz, P. D. Initiation of HIV-1 Gag lattice assembly is required for recognition of the viral genome packaging signal. eLife 12, e83548 (2023).","journal-title":"eLife"},{"key":"1327_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001200","volume":"6","author":"SB Kutluay","year":"2010","unstructured":"Kutluay, S. B. & Bieniasz, P. D. Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog. 6, e1001200 (2010).","journal-title":"PLoS Pathog."},{"key":"1327_CR73","first-page":"E201","volume":"113","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. HIV-1 RNA genome dimerizes on the plasma membrane in the presence of Gag protein. Proc. Natl Acad. Sci. USA 113, E201\u2013E208 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR74","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06998","volume":"454","author":"N Jouvenet","year":"2008","unstructured":"Jouvenet, N., Bieniasz, P. D. & Simon, S. M. Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 454, 236\u2013240 (2008).","journal-title":"Nature"},{"key":"1327_CR75","doi-asserted-by":"publisher","first-page":"11090","DOI":"10.1073\/pnas.0903535106","volume":"106","author":"JAG Briggs","year":"2009","unstructured":"Briggs, J. A. G. et al. Structure and assembly of immature HIV. Proc. Natl Acad. Sci. USA 106, 11090\u201311095 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR76","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/sj.emboj.7601664","volume":"26","author":"ER Wright","year":"2007","unstructured":"Wright, E. R. et al. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 26, 2218\u20132226 (2007).","journal-title":"EMBO J."},{"key":"1327_CR77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/prot.340130204","volume":"13","author":"S Ros\u00e9","year":"1992","unstructured":"Ros\u00e9, S. et al. Characterization of HIV-1 p24 self-association using analytical affinity chromatography. Proteins 13, 112\u2013119 (1992).","journal-title":"Proteins"},{"key":"1327_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature13838","volume":"517","author":"FKM Schur","year":"2015","unstructured":"Schur, F. K. M. et al. Structure of the immature HIV-1 capsid in intact virus particles at 8.8 \u00c5 resolution. Nature 517, 505\u2013508 (2015).","journal-title":"Nature"},{"key":"1327_CR79","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1126\/science.aaf9620","volume":"353","author":"FK Schur","year":"2016","unstructured":"Schur, F. K. et al. An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation. Science 353, 506\u2013508 (2016).","journal-title":"Science"},{"key":"1327_CR80","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1128\/JVI.74.12.5395-5402.2000","volume":"74","author":"MA Accola","year":"2000","unstructured":"Accola, M. A., Strack, B. & G\u00f6ttlinger, H. G. Efficient particle production by minimal gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74, 5395\u20135402 (2000).","journal-title":"J. Virol."},{"key":"1327_CR81","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1128\/JVI.77.9.5439-5450.2003","volume":"77","author":"UK von Schwedler","year":"2003","unstructured":"von Schwedler, U. K., Stray, K. M., Garrus, J. E. & Sundquist, W. I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77, 5439\u20135450 (2003).","journal-title":"J. Virol."},{"key":"1327_CR82","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1128\/JVI.00006-11","volume":"85","author":"SA Datta","year":"2011","unstructured":"Datta, S. A. et al. On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J. Virol. 85, 4111\u20134121 (2011).","journal-title":"J. Virol."},{"key":"1327_CR83","doi-asserted-by":"publisher","first-page":"9675","DOI":"10.1128\/JVI.78.18.9675-9688.2004","volume":"78","author":"D Melamed","year":"2004","unstructured":"Melamed, D. et al. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release. J. Virol. 78, 9675\u20139688 (2004).","journal-title":"J. Virol."},{"key":"1327_CR84","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1128\/jvi.68.8.4927-4936.1994","volume":"68","author":"F Mammano","year":"1994","unstructured":"Mammano, F., Ohagen, A., H\u00f6glund, S. & G\u00f6ttlinger, H. G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68, 4927\u20134936 (1994).","journal-title":"J. Virol."},{"key":"1327_CR85","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1110\/ps.04614804","volume":"13","author":"JL Newman","year":"2004","unstructured":"Newman, J. L., Butcher, E. W., Patel, D. T., Mikhaylenko, Y. & Summers, M. F. Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Protein Sci. 13, 2101\u20132107 (2004).","journal-title":"Protein Sci."},{"key":"1327_CR86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S0907444998007689","volume":"55","author":"DK Worthylake","year":"1999","unstructured":"Worthylake, D. K., Wang, H., Yoo, S., Sundquist, W. I. & Hill, C. P. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr. D. 55, 85\u201392 (1999).","journal-title":"Acta Crystallogr. D."},{"key":"1327_CR87","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/JVI.72.3.2072-2078.1998","volume":"72","author":"MA Accola","year":"1998","unstructured":"Accola, M. A., H\u00f6glund, S. & G\u00f6ttlinger, H. G. A putative \u03b1-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J. Virol. 72, 2072\u20132078 (1998).","journal-title":"J. Virol."},{"key":"1327_CR88","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17063","volume":"5","author":"JM Wagner","year":"2016","unstructured":"Wagner, J. M. et al. Crystal structure of an HIV assembly and maturation switch. eLife 5, e17063 (2016).","journal-title":"eLife"},{"key":"1327_CR89","doi-asserted-by":"publisher","first-page":"E9401","DOI":"10.1073\/pnas.1811237115","volume":"115","author":"S Mattei","year":"2018","unstructured":"Mattei, S. et al. High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation. Proc. Natl Acad. Sci. USA 115, E9401\u2013E9410 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR90","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1073\/pnas.191224698","volume":"98","author":"S Campbell","year":"2001","unstructured":"Campbell, S. et al. Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc. Natl Acad. Sci. USA 98, 10875\u201310879 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR91","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-018-0396-4","volume":"560","author":"RA Dick","year":"2018","unstructured":"Dick, R. A. et al. Inositol phosphates are assembly co-factors for HIV-1. Nature 560, 509\u2013512 (2018).","journal-title":"Nature"},{"key":"1327_CR92","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.celrep.2019.11.050","volume":"29","author":"DL Mallery","year":"2019","unstructured":"Mallery, D. L. et al. Cellular IP(6) levels limit HIV production while viruses that cannot efficiently package IP(6) are attenuated for infection and replication. Cell Rep. 29, 3983\u20133996 (2019).","journal-title":"Cell Rep."},{"key":"1327_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008646","volume":"16","author":"CL Ricana","year":"2020","unstructured":"Ricana, C. L., Lyddon, T. D., Dick, R. A. & Johnson, M. C. Primate lentiviruses require inositol hexakisphosphate (IP6) or inositol pentakisphosphate (IP5) for the production of viral particles. PLoS Pathog. 16, e1008646 (2020).","journal-title":"PLoS Pathog."},{"key":"1327_CR94","doi-asserted-by":"publisher","first-page":"eabe4716","DOI":"10.1126\/sciadv.abe4716","volume":"7","author":"DL Mallery","year":"2021","unstructured":"Mallery, D. L. et al. A stable immature lattice packages IP(6) for HIV capsid maturation. Sci. Adv. 7, eabe4716 (2021).","journal-title":"Sci. Adv."},{"key":"1327_CR95","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.35335","volume":"7","author":"DL Mallery","year":"2018","unstructured":"Mallery, D. L. et al. IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis. eLife 7, e35335 (2018).","journal-title":"eLife"},{"key":"1327_CR96","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41594-022-00887-4","volume":"30","author":"N Renner","year":"2023","unstructured":"Renner, N. et al. HIV-1 is dependent on its immature lattice to recruit IP6 for mature capsid assembly. Nat. Struct. Mol. Biol. 30, 370\u2013382 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1327_CR97","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/v14081729","volume":"14","author":"B Anokhin","year":"2022","unstructured":"Anokhin, B. & Spearman, P. Viral and host factors regulating HIV-1 envelope protein trafficking and particle incorporation. Viruses 14, 1729 (2022).","journal-title":"Viruses"},{"key":"1327_CR98","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature04817","volume":"441","author":"P Zhu","year":"2006","unstructured":"Zhu, P. et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847\u2013852 (2006).","journal-title":"Nature"},{"key":"1327_CR99","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1073\/pnas.97.1.343","volume":"97","author":"T Murakami","year":"2000","unstructured":"Murakami, T. & Freed, E. O. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc. Natl Acad. Sci. USA 97, 343\u2013348 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR100","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jmb.2011.04.042","volume":"410","author":"MA Checkley","year":"2011","unstructured":"Checkley, M. A., Luttge, B. G. & Freed, E. O. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol. 410, 582\u2013608 (2011).","journal-title":"J. Mol. Biol."},{"key":"1327_CR101","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1128\/JVI.74.8.3548-3554.2000","volume":"74","author":"T Murakami","year":"2000","unstructured":"Murakami, T. & Freed, E. O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and \u03b1-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74, 3548\u20133554 (2000).","journal-title":"J. Virol."},{"key":"1327_CR102","doi-asserted-by":"publisher","first-page":"e01742","DOI":"10.1128\/jvi.01742-23","volume":"98","author":"A Alfadhli","year":"2024","unstructured":"Alfadhli, A., Romanaggi, C., Barklis, R. L. & Barklis, E. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein. J. Virol. 98, e01742-23 (2024).","journal-title":"J. Virol."},{"key":"1327_CR103","doi-asserted-by":"publisher","first-page":"25269","DOI":"10.1073\/pnas.1910008116","volume":"116","author":"N Pezeshkian","year":"2019","unstructured":"Pezeshkian, N., Groves, N. S. & van Engelenburg, S. B. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation. Proc. Natl Acad. Sci. USA 116, 25269\u201325277 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR104","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.str.2017.09.010","volume":"25","author":"RE Murphy","year":"2017","unstructured":"Murphy, R. E., Samal, A. B., Vlach, J. & Saad, J. S. Solution structure and membrane interaction of the cytoplasmic tail of HIV-1 gp41 protein. Structure 25, 1708\u20131718 (2017).","journal-title":"Structure"},{"key":"1327_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16165-0","volume":"11","author":"A Piai","year":"2020","unstructured":"Piai, A. et al. Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein. Nat. Commun. 11, 2317 (2020).","journal-title":"Nat. Commun."},{"key":"1327_CR106","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1021\/jacs.1c01762","volume":"143","author":"A Piai","year":"2021","unstructured":"Piai, A. et al. NMR model of the entire membrane-interacting region of the HIV-1 fusion protein and its perturbation of membrane morphology. J. Am. Chem. Soc. 143, 6609\u20136615 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1327_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200794119","volume":"119","author":"AB Samal","year":"2022","unstructured":"Samal, A. B., Green, T. J. & Saad, J. S. Atomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation. Proc. Natl Acad. Sci. USA 119, e2200794119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR108","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cell.2022.01.013","volume":"185","author":"V Mangala Prasad","year":"2022","unstructured":"Mangala Prasad, V. et al. Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice. Cell 185, 641\u2013653 (2022).","journal-title":"Cell"},{"key":"1327_CR109","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1021\/jacs.5c04597","volume":"147","author":"M Chaubey","year":"2025","unstructured":"Chaubey, M. et al. Specific interactions between HIV-1 Env cytoplasmic tail and gag matrix domain probed by NMR. J. Am. Chem. Soc. 147, 17561\u201317565 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"1327_CR110","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1226359","volume":"338","author":"J Chojnacki","year":"2012","unstructured":"Chojnacki, J. et al. Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science 338, 524\u2013528 (2012).","journal-title":"Science"},{"key":"1327_CR111","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/JVI.78.2.1026-1031.2004","volume":"78","author":"T Murakami","year":"2004","unstructured":"Murakami, T., Ablan, S., Freed, E. O. & Tanaka, Y. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J. Virol. 78, 1026\u20131031 (2004).","journal-title":"J. Virol."},{"key":"1327_CR112","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1128\/JVI.78.7.3429-3435.2004","volume":"78","author":"DJ Wyma","year":"2004","unstructured":"Wyma, D. J. et al. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 78, 3429\u20133435 (2004).","journal-title":"J. Virol."},{"key":"1327_CR113","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/jvi.68.3.1773-1781.1994","volume":"68","author":"A Rein","year":"1994","unstructured":"Rein, A., Mirro, J., Haynes, J. G., Ernst, S. M. & Nagashima, K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68, 1773\u20131781 (1994).","journal-title":"J. Virol."},{"key":"1327_CR114","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1128\/jvi.68.7.4620-4627.1994","volume":"68","author":"BA Brody","year":"1994","unstructured":"Brody, B. A., Rhee, S. S. & Hunter, E. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68, 4620\u20134627 (1994).","journal-title":"J. Virol."},{"key":"1327_CR115","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/jvi.64.8.3770-3778.1990","volume":"64","author":"NR Rice","year":"1990","unstructured":"Rice, N. R. et al. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64, 3770\u20133778 (1990).","journal-title":"J. Virol."},{"key":"1327_CR116","doi-asserted-by":"publisher","first-page":"e00631","DOI":"10.1128\/jvi.00631-23","volume":"97","author":"G Lerner","year":"2023","unstructured":"Lerner, G., Ding, L. & Spearman, P. Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation. J. Virol. 97, e00631\u201323 (2023).","journal-title":"J. Virol."},{"key":"1327_CR117","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/v13091729","volume":"13","author":"MI Barr\u00eda","year":"2021","unstructured":"Barr\u00eda, M. I. et al. Endocytic motif on a biotin-tagged HIV-1 Env modulates the co-transfer of Env and Gag during cell-to-cell transmission. Viruses 13, 1729 (2021).","journal-title":"Viruses"},{"key":"1327_CR118","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/v14010038","volume":"14","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. A replication-competent HIV clone carrying GFP\u2013Env reveals rapid Env recycling at the HIV-1 T cell virological synapse. Viruses 14, 38 (2021).","journal-title":"Viruses"},{"key":"1327_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010507","volume":"18","author":"SP Lawrence","year":"2022","unstructured":"Lawrence, S. P. et al. A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection. PLoS Pathog. 18, e1010507 (2022).","journal-title":"PLoS Pathog."},{"key":"1327_CR120","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-025-08950-y","volume":"642","author":"JH Hurley","year":"2025","unstructured":"Hurley, J. H., Coyne, A. N., Mi\u0105czy\u0144ska, M. & Stenmark, H. The expanding repertoire of ESCRT functions in cell biology and disease. Nature 642, 877\u2013888 (2025).","journal-title":"Nature"},{"key":"1327_CR121","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1073\/pnas.88.8.3195","volume":"88","author":"HG G\u00f6ttlinger","year":"1991","unstructured":"G\u00f6ttlinger, H. G., Dorfman, T., Sodroski, J. G. & Haseltine, W. A. Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proc. Natl Acad. Sci. USA 88, 3195\u20133199 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR122","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1128\/jvi.69.11.6810-6818.1995","volume":"69","author":"M Huang","year":"1995","unstructured":"Huang, M., Orenstein, J. M., Martin, M. A. & Freed, E. O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69, 6810\u20136818 (1995).","journal-title":"J. Virol."},{"key":"1327_CR123","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.032511899","volume":"99","author":"DG Demirov","year":"2002","unstructured":"Demirov, D. G., Ono, A., Orenstein, J. M. & Freed, E. O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl Acad. Sci. USA 99, 955\u2013960 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR124","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(01)00506-2","volume":"107","author":"JE Garrus","year":"2001","unstructured":"Garrus, J. E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55\u201365 (2001).","journal-title":"Cell"},{"key":"1327_CR125","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1073\/pnas.131059198","volume":"98","author":"L VerPlank","year":"2001","unstructured":"VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl Acad. Sci. USA 98, 7724\u20137729 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR126","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm1201-1313","volume":"7","author":"J Martin-Serrano","year":"2001","unstructured":"Martin-Serrano, J., Zang, T. & Bieniasz, P. D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313\u20131319 (2001).","journal-title":"Nat. Med."},{"key":"1327_CR127","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.chom.2013.08.012","volume":"14","author":"J Votteler","year":"2013","unstructured":"Votteler, J. & Sundquist, W. esleyI. Virus budding and the ESCRT pathway. Cell Host Microbe 14, 232\u2013241 (2013).","journal-title":"Cell Host Microbe"},{"key":"1327_CR128","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2007.01.035","volume":"128","author":"RD Fisher","year":"2007","unstructured":"Fisher, R. D. et al. Structural and biochemical studies of ALIX\/AIP1 and its role in retrovirus budding. Cell 128, 841\u2013852 (2007).","journal-title":"Cell"},{"key":"1327_CR129","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1128\/JVI.00314-07","volume":"81","author":"Y Usami","year":"2007","unstructured":"Usami, Y., Popov, S. & G\u00f6ttlinger, H. G. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX\/AIP1 depends on its CHMP4 binding site. J. Virol. 81, 6614\u20136622 (2007).","journal-title":"J. Virol."},{"key":"1327_CR130","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chom.2011.02.004","volume":"9","author":"E Morita","year":"2011","unstructured":"Morita, E. et al. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9, 235\u2013242 (2011).","journal-title":"Cell Host Microbe"},{"key":"1327_CR131","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.1073\/pnas.1321655111","volume":"111","author":"M Bleck","year":"2014","unstructured":"Bleck, M. et al. Temporal and spatial organization of ESCRT protein recruitment during HIV-1 budding. Proc. Natl Acad. Sci. USA 111, 12211\u201312216 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR132","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ncb2207","volume":"13","author":"N Jouvenet","year":"2011","unstructured":"Jouvenet, N., Zhadina, M., Bieniasz, P. D. & Simon, S. M. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat. Cell Biol. 13, 394\u2013401 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR133","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1126\/science.1247786","volume":"343","author":"SB Van Engelenburg","year":"2014","unstructured":"Van Engelenburg, S. B. et al. Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits. Science 343, 653\u2013656 (2014).","journal-title":"Science"},{"key":"1327_CR134","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virusres.2019.03.014","volume":"265","author":"KD Pedro","year":"2019","unstructured":"Pedro, K. D., Henderson, A. J. & Agosto, L. M. Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. Virus Res. 265, 115\u2013121 (2019).","journal-title":"Virus Res."},{"key":"1327_CR135","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tim.2015.02.003","volume":"23","author":"LM Agosto","year":"2015","unstructured":"Agosto, L. M., Uchil, P. D. & Mothes, W. HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy. Trends Microbiol. 23, 289\u2013295 (2015).","journal-title":"Trends Microbiol."},{"key":"1327_CR136","doi-asserted-by":"crossref","unstructured":"Law, K. M., Satija, N., Esposito, A. M. & Chen, B. K. in Advances in Virus Research Vol. 95 (eds Kielian, M., Maramorosch, K. & Mettenleiter, T. C.) 43\u201385 (Academic, 2016).","DOI":"10.1016\/bs.aivir.2016.03.001"},{"key":"1327_CR137","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn0042","volume":"10","author":"Y Hikichi","year":"2024","unstructured":"Hikichi, Y., Grover, J. R., Sch\u00e4fer, A., Mothes, W. & Freed, E. O. Epistatic pathways can drive HIV-1 escape from integrase strand transfer inhibitors. Sci. Adv. 10, eadn0042 (2024).","journal-title":"Sci. Adv."},{"key":"1327_CR138","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature10347","volume":"477","author":"A Sigal","year":"2011","unstructured":"Sigal, A. et al. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 477, 95\u201398 (2011).","journal-title":"Nature"},{"key":"1327_CR139","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/v13050839","volume":"13","author":"IT Weber","year":"2021","unstructured":"Weber, I. T., Wang, Y. F. & Harrison, R. W. HIV protease: historical perspective and current research. Viruses 13, 839 (2021).","journal-title":"Viruses"},{"key":"1327_CR140","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1006\/viro.1993.1174","volume":"193","author":"V Karacostas","year":"1993","unstructured":"Karacostas, V., Wolffe, E. J., Nagashima, K., Gonda, M. A. & Moss, B. Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193, 661\u2013671 (1993).","journal-title":"Virology"},{"key":"1327_CR141","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1128\/jvi.66.1.567-572.1992","volume":"66","author":"HG Kr\u00e4usslich","year":"1992","unstructured":"Kr\u00e4usslich, H. G. Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J. Virol. 66, 567\u2013572 (1992).","journal-title":"J. Virol."},{"key":"1327_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020119","volume":"2","author":"A Figueiredo","year":"2006","unstructured":"Figueiredo, A. et al. Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol. PLoS Pathog. 2, e119 (2006).","journal-title":"PLoS Pathog."},{"key":"1327_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-7-89","volume":"7","author":"D Jochmans","year":"2010","unstructured":"Jochmans, D. et al. Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Retrovirology 7, 89 (2010).","journal-title":"Retrovirology"},{"key":"1327_CR144","doi-asserted-by":"publisher","first-page":"eabe1707","DOI":"10.1126\/science.abe1707","volume":"371","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science 371, eabe1707 (2021).","journal-title":"Science"},{"key":"1327_CR145","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn2038","volume":"15","author":"CJ Balibar","year":"2023","unstructured":"Balibar, C. J. et al. Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1. Sci. Transl. Med. 15, eabn2038 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1327_CR146","doi-asserted-by":"publisher","first-page":"e02198","DOI":"10.1128\/jvi.02198-21","volume":"96","author":"CO Tabler","year":"2022","unstructured":"Tabler, C. O. et al. The HIV-1 viral protease is activated during assembly and budding prior to particle release. J. Virol. 96, e02198-21 (2022).","journal-title":"J. Virol."},{"key":"1327_CR147","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.84881","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo, S., Saha, I., Saffarian, S. & Johnson, M. E. Structure of the HIV immature lattice allows for essential lattice remodeling within budded virions. eLife 12, e84881 (2023).","journal-title":"eLife"},{"key":"1327_CR148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219475120","volume":"120","author":"AA Waheed","year":"2023","unstructured":"Waheed, A. A. et al. Neutral sphingomyelinase 2 is required for HIV-1 maturation. Proc. Natl Acad. Sci. USA 120, e2219475120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR149","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219543120","volume":"120","author":"SW Yoo","year":"2023","unstructured":"Yoo, S. W. et al. Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound. Proc. Natl Acad. Sci. USA 120, e2219543120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR150","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn9874","volume":"8","author":"J Harrison","year":"2022","unstructured":"Harrison, J. et al. Cryo-EM structure of the HIV-1 Pol polyprotein provides insights into virion maturation. Sci. Adv. 8, eabn9874 (2022).","journal-title":"Sci. Adv."},{"key":"1327_CR151","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.1128\/JVI.79.16.10247-10257.2005","volume":"79","author":"J Wapling","year":"2005","unstructured":"Wapling, J., Moore, K. L., Sonza, S., Mak, J. & Tachedjian, G. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J. Virol. 79, 10247\u201310257 (2005).","journal-title":"J. Virol."},{"key":"1327_CR152","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1128\/JVI.02306-12","volume":"87","author":"S Sudo","year":"2013","unstructured":"Sudo, S. et al. Efavirenz enhances HIV-1 Gag processing at the plasma membrane through Gag-Pol dimerization. J. Virol. 87, 3348\u20133360 (2013).","journal-title":"J. Virol."},{"key":"1327_CR153","doi-asserted-by":"publisher","first-page":"12234","DOI":"10.1073\/pnas.1400027111","volume":"111","author":"H Hayashi","year":"2014","unstructured":"Hayashi, H. et al. Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir. Proc. Natl Acad. Sci. USA 111, 12234\u201312239 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR154","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.febslet.2004.11.099","volume":"579","author":"G Tachedjian","year":"2005","unstructured":"Tachedjian, G., Moore, K. L., Goff, S. P. & Sluis-Cremer, N. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation. FEBS Lett. 579, 379\u2013384 (2005).","journal-title":"FEBS Lett."},{"key":"1327_CR155","doi-asserted-by":"crossref","unstructured":"Pettit, S. C., Sheng, N., Tritch, R., Erickson-Viitanen, S. & Swanstrom, R. in Aspartic Proteinases: Retroviral and Cellular Enzymes (ed. Michael, N. G. J.) 15\u201325 (Springer, 1998).","DOI":"10.1007\/978-1-4615-5373-1_2"},{"key":"1327_CR156","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.virol.2010.01.028","volume":"400","author":"MA Checkley","year":"2010","unstructured":"Checkley, M. A., Luttge, B. G., Soheilian, F., Nagashima, K. & Freed, E. O. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation. Virology 400, 137\u2013144 (2010).","journal-title":"Virology"},{"key":"1327_CR157","doi-asserted-by":"publisher","first-page":"29692","DOI":"10.1074\/jbc.M109.027144","volume":"284","author":"B M\u00fcller","year":"2009","unstructured":"M\u00fcller, B. et al. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J. Biol. Chem. 284, 29692\u201329703 (2009).","journal-title":"J. Biol. Chem."},{"key":"1327_CR158","doi-asserted-by":"publisher","first-page":"13722","DOI":"10.1128\/JVI.02271-14","volume":"88","author":"S Mattei","year":"2014","unstructured":"Mattei, S. et al. Induced maturation of human immunodeficiency virus. J. Virol. 88, 13722\u201313731 (2014).","journal-title":"J. Virol."},{"key":"1327_CR159","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/35030177","volume":"407","author":"S Li","year":"2000","unstructured":"Li, S., Hill, C. P., Sundquist, W. I. & Finch, J. T. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407, 409\u2013413 (2000).","journal-title":"Nature"},{"key":"1327_CR160","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1073\/pnas.1920631117","volume":"117","author":"RC Burdick","year":"2020","unstructured":"Burdick, R. C. et al. HIV-1 uncoats in the nucleus near sites of integration. Proc. Natl Acad. Sci. USA 117, 5486\u20135493 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR161","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2021.01.025","volume":"184","author":"V Zila","year":"2021","unstructured":"Zila, V. et al. Cone-shaped HIV-1 capsids are transported through intact nuclear pores. Cell 184, 1032\u20131046 (2021).","journal-title":"Cell"},{"key":"1327_CR162","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41564-020-0735-8","volume":"5","author":"A Dharan","year":"2020","unstructured":"Dharan, A., Bachmann, N., Talley, S., Zwikelmaier, V. & Campbell, E. M. Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus. Nat. Microbiol. 5, 1088\u20131095 (2020).","journal-title":"Nat. Microbiol."},{"key":"1327_CR163","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/v12090940","volume":"12","author":"AB Kleinpeter","year":"2020","unstructured":"Kleinpeter, A. B. & Freed, E. O. HIV-1 maturation: lessons learned from inhibitors. Viruses 12, 940 (2020).","journal-title":"Viruses"},{"key":"1327_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01856-y","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Quenching protein dynamics interferes with HIV capsid maturation. Nat. Commun. 8, 1779 (2017).","journal-title":"Nat. Commun."},{"key":"1327_CR165","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1128\/JVI.02204-15","volume":"90","author":"J Fontana","year":"2016","unstructured":"Fontana, J. et al. Identification of an HIV-1 mutation in spacer peptide 1 that stabilizes the immature CA\u2013SP1 lattice. J. Virol. 90, 972\u2013978 (2016).","journal-title":"J. Virol."},{"key":"1327_CR166","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature19098","volume":"536","author":"DA Jacques","year":"2016","unstructured":"Jacques, D. A. et al. HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis. Nature 536, 349\u2013353 (2016).","journal-title":"Nature"},{"key":"1327_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001015","volume":"18","author":"C Xu","year":"2020","unstructured":"Xu, C. et al. Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis. PLoS Biol. 18, e3001015 (2020).","journal-title":"PLoS Biol."},{"key":"1327_CR168","doi-asserted-by":"publisher","first-page":"eabc8420","DOI":"10.1126\/science.abc8420","volume":"370","author":"DE Christensen","year":"2020","unstructured":"Christensen, D. E., Ganser-Pornillos, B. K., Johnson, J. S., Pornillos, O. & Sundquist, W. I. Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science 370, eabc8420 (2020).","journal-title":"Science"},{"key":"1327_CR169","doi-asserted-by":"publisher","first-page":"e02820-20","DOI":"10.1128\/mBio.02820-20","volume":"11","author":"J Jennings","year":"2020","unstructured":"Jennings, J., Shi, J., Varadarajan, J., Jamieson, P. J. & Aiken, C. The host cell metabolite inositol hexakisphosphate promotes efficient endogenous HIV-1 reverse transcription by stabilizing the viral capsid. mBio 11, e02820-20 (2020).","journal-title":"mBio"},{"key":"1327_CR170","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1432-1033.1997.t01-1-00592.x","volume":"249","author":"I Gross","year":"1997","unstructured":"Gross, I., Hohenberg, H. & Kr\u00e4usslich, H.-G. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249, 592\u2013600 (1997).","journal-title":"Eur. J. Biochem."},{"key":"1327_CR171","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1128\/jvi.66.8.4874-4883.1992","volume":"66","author":"LS Ehrlich","year":"1992","unstructured":"Ehrlich, L. S., Agresta, B. E. & Carter, C. A. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66, 4874\u20134883 (1992).","journal-title":"J. Virol."},{"key":"1327_CR172","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220545120","volume":"120","author":"CM Highland","year":"2023","unstructured":"Highland, C. M., Tan, A., Rica\u00f1a, C. L., Briggs, J. A. G. & Dick, R. A. Structural insights into HIV-1 polyanion-dependent capsid lattice formation revealed by single particle cryo-EM. Proc. Natl Acad. Sci. USA 120, e2220545120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR173","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220557120","volume":"120","author":"JCV Stacey","year":"2023","unstructured":"Stacey, J. C. V. et al. Two structural switches in HIV-1 capsid regulate capsid curvature and host factor binding. Proc. Natl Acad. Sci. USA 120, e2220557120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR174","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41594-022-00913-5","volume":"30","author":"RT Schirra","year":"2023","unstructured":"Schirra, R. T. et al. A molecular switch modulates assembly and host factor binding of the HIV-1 capsid. Nat. Struct. Mol. Biol. 30, 383\u2013390 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1327_CR175","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc6465","volume":"6","author":"A Yu","year":"2020","unstructured":"Yu, A., Lee, E. M. Y., Jin, J. & Voth, G. A. Atomic-scale characterization of mature HIV-1 capsid stabilization by inositol hexakisphosphate (IP6). Sci. Adv. 6, eabc6465 (2020).","journal-title":"Sci. Adv."},{"key":"1327_CR176","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add7434","volume":"9","author":"M Gupta","year":"2023","unstructured":"Gupta, M., Pak, A. J. & Voth, G. A. Critical mechanistic features of HIV-1 viral capsid assembly. Sci. Adv. 9, eadd7434 (2023).","journal-title":"Sci. Adv."},{"key":"1327_CR177","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj5715","volume":"7","author":"T Ni","year":"2021","unstructured":"Ni, T. et al. Structure of native HIV-1 cores and their interactions with IP6 and CypA. Sci. Adv. 7, eabj5715 (2021).","journal-title":"Sci. Adv."},{"key":"1327_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009164","volume":"17","author":"N Renner","year":"2021","unstructured":"Renner, N. et al. A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly. PLoS Pathog. 17, e1009164 (2021).","journal-title":"PLoS Pathog."},{"key":"1327_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51971-w","volume":"15","author":"A Kleinpeter","year":"2024","unstructured":"Kleinpeter, A. et al. HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly. Nat. Commun. 15, 8017 (2024).","journal-title":"Nat. Commun."},{"key":"1327_CR180","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/v16071038","volume":"16","author":"RT Schirra","year":"2024","unstructured":"Schirra, R. T., dos, Santos, N. F. B., Ganser-Pornillos, B. K. & Pornillos, O. Arg18 substitutions reveal the capacity of the HIV-1 capsid protein for non-fullerene assembly. Viruses 16, 1038 (2024).","journal-title":"Viruses"},{"key":"1327_CR181","doi-asserted-by":"publisher","first-page":"13655","DOI":"10.1128\/JVI.01408-13","volume":"87","author":"PW Keller","year":"2013","unstructured":"Keller, P. W. et al. A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition. J. Virol. 87, 13655\u201313664 (2013).","journal-title":"J. Virol."},{"key":"1327_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6854","volume":"6","author":"GA Frank","year":"2015","unstructured":"Frank, G. A. et al. Maturation of the HIV-1 core by a non-diffusional phase transition. Nat. Commun. 6, 5854 (2015).","journal-title":"Nat. Commun."},{"key":"1327_CR183","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1128\/JVI.02997-14","volume":"89","author":"CL Woodward","year":"2015","unstructured":"Woodward, C. L., Cheng, S. N. & Jensen, G. J. Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core. J. Virol. 89, 1267\u20131277 (2015).","journal-title":"J. Virol."},{"key":"1327_CR184","doi-asserted-by":"publisher","unstructured":"Meuser, M. E. et al. A hybrid gag lattice as a structural intermediate in HIV-1 maturation. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.01.10.698794 (2026).","DOI":"10.64898\/2026.01.10.698794"},{"key":"1327_CR185","doi-asserted-by":"publisher","first-page":"13708","DOI":"10.1128\/JVI.01704-12","volume":"86","author":"AD Marco","year":"2012","unstructured":"Marco, A. D. et al. Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity. J. Virol. 86, 13708\u201313716 (2012).","journal-title":"J. Virol."},{"key":"1327_CR186","doi-asserted-by":"publisher","first-page":"10047","DOI":"10.1128\/JVI.02496-06","volume":"81","author":"LV Coren","year":"2007","unstructured":"Coren, L. V. et al. Mutational analysis of the C-terminal Gag cleavage sites in human immunodeficiency virus type 1. J. Virol. 81, 10047\u201310054 (2007).","journal-title":"J. Virol."},{"key":"1327_CR187","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv4356","volume":"11","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Structural maturation of the matrix lattice is not required for HIV-1 particle infectivity. Sci. Adv. 11, eadv4356 (2025).","journal-title":"Sci. Adv."},{"key":"1327_CR188","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/rna.7.6.14115","volume":"7","author":"JG Levin","year":"2010","unstructured":"Levin, J. G., Mitra, M., Mascarenhas, A. & Musier-Forsyth, K. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 7, 754\u2013774 (2010).","journal-title":"RNA Biol."},{"key":"1327_CR189","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adz8980","volume":"11","author":"Y Hikichi","year":"2025","unstructured":"Hikichi, Y. et al. Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors. Sci. Adv. 11, eadz8980 (2025).","journal-title":"Sci. Adv."},{"key":"1327_CR190","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1128\/jvi.69.5.2729-2736.1995","volume":"69","author":"A Engelman","year":"1995","unstructured":"Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A. & Craigie, R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69, 2729\u20132736 (1995).","journal-title":"J. Virol."},{"key":"1327_CR191","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1073\/pnas.1300703110","volume":"110","author":"KA Jurado","year":"2013","unstructured":"Jurado, K. A. et al. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Proc. Natl Acad. Sci. USA 110, 8690\u20138695 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR192","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2016.07.044","volume":"166","author":"JJ Kessl","year":"2016","unstructured":"Kessl, J. J. et al. HIV-1 integrase binds the viral RNA genome and is essential during virion morphogenesis. Cell 166, 1257\u20131268 (2016).","journal-title":"Cell"},{"key":"1327_CR193","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54311","volume":"9","author":"JL Elliott","year":"2020","unstructured":"Elliott, J. L. et al. Integrase\u2013RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis. eLife 9, e54311 (2020).","journal-title":"eLife"},{"key":"1327_CR194","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00431-22","volume":"13","author":"CS Mugisha","year":"2022","unstructured":"Mugisha, C. S. et al. Emergence of compensatory mutations reveals the importance of electrostatic interactions between HIV-1 integrase and genomic RNA. mBio 13,\u00a0e0043122 (2022).","journal-title":"mBio"},{"key":"1327_CR195","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41586-026-10154-x","volume":"652","author":"MR Singer","year":"2026","unstructured":"Singer, M. R. et al. Integrase anchors viral RNA to the HIV-1 capsid interior. Nature 652, 1068\u20131075\u00a0(2026).","journal-title":"Nature"},{"key":"1327_CR196","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/molecules25071687","volume":"25","author":"A Dick","year":"2020","unstructured":"Dick, A. & Cocklin, S. Recent advances in HIV-1 Gag inhibitor design and development. Molecules 25, 1687 (2020).","journal-title":"Molecules"},{"key":"1327_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36569-y","volume":"14","author":"S Sarkar","year":"2023","unstructured":"Sarkar, S. et al. Structural basis of HIV-1 maturation inhibitor binding and activity. Nat. Commun. 14, 1237 (2023).","journal-title":"Nat. Commun."},{"key":"1327_CR198","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.1073\/pnas.1806806115","volume":"115","author":"MD Purdy","year":"2018","unstructured":"Purdy, M. D. et al. MicroED structures of HIV-1 Gag CTD\u2013SP1 reveal binding interactions with the maturation inhibitor bevirimat. Proc. Natl Acad. Sci. USA 115, 13258\u201313263 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR199","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1128\/JVI.01926-10","volume":"85","author":"PW Keller","year":"2011","unstructured":"Keller, P. W., Adamson, C. S., Heymann, J. B., Freed, E. O. & Steven, A. C. HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice. J. Virol. 85, 1420\u20131428 (2011).","journal-title":"J. Virol."},{"key":"1327_CR200","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.1073\/pnas.2234683100","volume":"100","author":"F Li","year":"2003","unstructured":"Li, F. et al. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl Acad. Sci. USA 100, 13555\u201313560 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR201","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1128\/JVI.78.2.922-929.2004","volume":"78","author":"J Zhou","year":"2004","unstructured":"Zhou, J. et al. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J. Virol. 78, 922\u2013929 (2004).","journal-title":"J. Virol."},{"key":"1327_CR202","first-page":"162","volume":"9","author":"K Salzwedel","year":"2007","unstructured":"Salzwedel, K., Martin, D. E. & Sakalian, M. Maturation inhibitors: a new therapeutic class targets the virus structure. AIDS Rev. 9, 162\u2013172 (2007).","journal-title":"AIDS Rev."},{"key":"1327_CR203","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-7-36","volume":"7","author":"CS Adamson","year":"2010","unstructured":"Adamson, C. S., Sakalian, M., Salzwedel, K. & Freed, E. O. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat. Retrovirology 7, 36 (2010).","journal-title":"Retrovirology"},{"key":"1327_CR204","doi-asserted-by":"publisher","first-page":"02017","DOI":"10.1128\/JVI.02017-18","volume":"93","author":"E Urano","year":"2019","unstructured":"Urano, E. et al. Resistance to second-generation HIV-1 maturation inhibitors. J. Virol. 93, 02017\u201302018 (2019).","journal-title":"J. Virol."},{"key":"1327_CR205","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1021\/acsmedchemlett.8b00656","volume":"10","author":"A Regueiro-Ren","year":"2019","unstructured":"Regueiro-Ren, A., Dicker, I. B., Hanumegowda, U. & Meanwell, N. A. Second generation inhibitors of HIV-1 maturation. ACS Med. Chem. Lett. 10, 287\u2013294 (2019).","journal-title":"ACS Med. Chem. Lett."},{"key":"1327_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1093","volume":"11","author":"PD Benn","year":"2023","unstructured":"Benn, P. D. et al. A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937. Pharmacol. Res. Perspect. 11, e01093 (2023).","journal-title":"Pharmacol. Res. Perspect."},{"key":"1327_CR207","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/cid\/ciab1065","volume":"75","author":"CD Spinner","year":"2022","unstructured":"Spinner, C. D. et al. Phase IIa proof-of-concept evaluation of the antiviral efficacy, safety, tolerability, and pharmacokinetics of the next-generation maturation inhibitor GSK3640254. Clin. Infect. Dis. 75, 786\u2013794 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1327_CR208","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1021\/acsmedchemlett.4c00419","volume":"15","author":"S-Y Sit","year":"2024","unstructured":"Sit, S.-Y. et al. Invention of VH-937, a potent HIV-1 maturation inhibitor with the potential for infrequent oral dosing in humans. ACS Med. Chem. Lett. 15, 1997\u20132004 (2024).","journal-title":"ACS Med. Chem. Lett."},{"key":"1327_CR209","doi-asserted-by":"publisher","first-page":"34487","DOI":"10.1021\/jacs.5c08455","volume":"147","author":"R Zadorozhnyi","year":"2025","unstructured":"Zadorozhnyi, R. et al. Structural basis for HIV-1 maturation inhibition by PF-46396 determined by MAS NMR. J. Am. Chem. Soc. 147, 34487\u201334497 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"1327_CR210","first-page":"42685","volume":"147","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Distinct target site of lenacapavir in immature HIV-1 and concurrent binding with the maturation inhibitor bevirimat. J. Am. Chem. Soc. 147, 42685\u201342700 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"1327_CR211","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nchembio.370","volume":"6","author":"F Christ","year":"2010","unstructured":"Christ, F. et al. Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication. Nat. Chem. Biol. 6, 442\u2013448 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"1327_CR212","doi-asserted-by":"publisher","first-page":"16801","DOI":"10.1074\/jbc.M112.354373","volume":"287","author":"JJ Kessl","year":"2012","unstructured":"Kessl, J. J. et al. Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors. J. Biol. Chem. 287, 16801\u201316811 (2012).","journal-title":"J. Biol. Chem."},{"key":"1327_CR213","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009671","volume":"17","author":"T Maehigashi","year":"2021","unstructured":"Maehigashi, T. et al. A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF\/p75-integrase interaction site. PLoS Pathog. 17, e1009671 (2021).","journal-title":"PLoS Pathog."},{"key":"1327_CR214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011097","volume":"19","author":"G Eilers","year":"2023","unstructured":"Eilers, G. et al. Structure of a HIV-1 IN-allosteric inhibitor complex at 2.93 \u00c5 resolution: routes to inhibitor optimization. PLoS Pathog. 19, e1011097 (2023).","journal-title":"PLoS Pathog."},{"key":"1327_CR215","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002584","volume":"14","author":"K Gupta","year":"2016","unstructured":"Gupta, K. et al. Structural basis for inhibitor-induced aggregation of HIV integrase. PLoS Biol. 14, e1002584 (2016).","journal-title":"PLoS Biol."},{"key":"1327_CR216","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00465-24","volume":"15","author":"T Dinh","year":"2024","unstructured":"Dinh, T. et al. The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir. mBio 15, e0046524 (2024).","journal-title":"mBio"},{"key":"1327_CR217","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/COH.0000000000000472","volume":"13","author":"SK Carnes","year":"2018","unstructured":"Carnes, S. K., Sheehan, J. H. & Aiken, C. Inhibitors of the HIV-1 capsid, a target of opportunity. Curr. Opin. HIV AIDS 13, 359\u2013365 (2018).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"1327_CR218","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001220","volume":"6","author":"WS Blair","year":"2010","unstructured":"Blair, W. S. et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 6, e1001220 (2010).","journal-title":"PLoS Pathog."},{"key":"1327_CR219","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41591-019-0560-x","volume":"25","author":"SR Yant","year":"2019","unstructured":"Yant, S. R. et al. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat. Med. 25, 1377\u20131384 (2019).","journal-title":"Nat. Med."},{"key":"1327_CR220","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","volume":"584","author":"JO Link","year":"2020","unstructured":"Link, J. O. et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature 584, 614\u2013618 (2020).","journal-title":"Nature"},{"key":"1327_CR221","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","volume":"386","author":"S Segal-Maurer","year":"2022","unstructured":"Segal-Maurer, S. et al. Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection. N. Engl. J. Med. 386, 1793\u20131803 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1327_CR222","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S2352-3018(22)00291-0","volume":"10","author":"SK Gupta","year":"2023","unstructured":"Gupta, S. K. et al. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. Lancet HIV 10, e15\u2013e23 (2023).","journal-title":"Lancet HIV"},{"key":"1327_CR223","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker, L.-G. et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N. Engl. J. Med. 391, 1179\u20131192 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1327_CR224","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","volume":"392","author":"CF Kelley","year":"2025","unstructured":"Kelley, C. F. et al. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N. Engl. J. Med. 392, 1261\u20131276 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1327_CR225","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.abb4808","volume":"370","author":"SM Bester","year":"2020","unstructured":"Bester, S. M. et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science 370, 360\u2013364 (2020).","journal-title":"Science"},{"key":"1327_CR226","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83605","volume":"13","author":"KMR Faysal","year":"2024","unstructured":"Faysal, K. M. R. et al. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure. eLife 13, e83605 (2024).","journal-title":"eLife"},{"key":"1327_CR227","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2420497122","volume":"122","author":"C Li","year":"2025","unstructured":"Li, C. et al. Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice. Proc. Natl Acad. Sci. USA 122, e2420497122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR228","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012537","volume":"20","author":"A Deshpande","year":"2024","unstructured":"Deshpande, A. et al. Elasticity of the HIV-1 core facilitates nuclear entry and infection. PLoS Pathog. 20, e1012537 (2024).","journal-title":"PLoS Pathog."},{"key":"1327_CR229","doi-asserted-by":"publisher","unstructured":"Hudait, A., Burdick, R. C., Bare, E. K., Pathak, V. K. & Voth, G. A. Lenacapavir-induced lattice hyperstabilization is central to HIV-1 capsid failure at the nuclear pore complex and in the cytoplasm. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.04.18.649524 (2025).","DOI":"10.1101\/2025.04.18.649524"},{"key":"1327_CR230","doi-asserted-by":"publisher","unstructured":"dos Santos, N. F. B. et al. Lenacapavir allosterically remodels the HIV-1 capsid. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.01.05.697065 (2026).","DOI":"10.64898\/2026.01.05.697065"},{"key":"1327_CR231","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2524995123","volume":"123","author":"M Gupta","year":"2025","unstructured":"Gupta, M. et al. Mechanistic insights into lenacapavir-induced off-pathway HIV-1 capsid assembly. Proc. Natl Acad. Sci. USA 123, e2524995123 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR232","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012862","volume":"21","author":"S-W Huang","year":"2025","unstructured":"Huang, S.-W. et al. The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir. PLoS Pathog. 21, e1012862 (2025).","journal-title":"PLoS Pathog."},{"key":"1327_CR233","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020054118","volume":"118","author":"A Tan","year":"2021","unstructured":"Tan, A., Pak, A. J., Morado, D. R., Voth, G. A. & Briggs, J. A. G. Immature HIV-1 assembles from Gag dimers leaving partial hexamers at lattice edges as potential substrates for proteolytic maturation. Proc. Natl Acad. Sci. USA 118, e2020054118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR234","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adz1069","volume":"11","author":"IK Hughes","year":"2025","unstructured":"Hughes, I. K., Hood, J. B., Qui\u00f1ones-Molina, A. A., Akiyama, H. & Gummuluru, S. Evasion of CARD8 activation during HIV-1 assembly. Sci. Adv. 11, eadz1069 (2025).","journal-title":"Sci. Adv."},{"key":"1327_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13689","volume":"7","author":"J Ning","year":"2016","unstructured":"Ning, J. et al. In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway. Nat. Commun. 7, 13689 (2016).","journal-title":"Nat. Commun."},{"key":"1327_CR236","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s42003-021-01999-1","volume":"4","author":"L Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a, L. et al. CryoET structures of immature HIV Gag reveal six-helix bundle. Commun. Biol. 4, 481 (2021).","journal-title":"Commun. Biol."},{"key":"1327_CR237","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/JVI.74.3.1168-1177.2000","volume":"74","author":"R Welker","year":"2000","unstructured":"Welker, R., Hohenberg, H., Tessmer, U. & Huckhagel, C. & Kr\u00e4usslich, H.-G. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 74, 1168\u20131177 (2000).","journal-title":"J. Virol."},{"key":"1327_CR238","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.1128\/JVI.01522-15","volume":"89","author":"J Fontana","year":"2015","unstructured":"Fontana, J. et al. Distribution and redistribution of HIV-1 nucleocapsid protein in immature, mature, and integrase-inhibited virions: a role for integrase in maturation. J. Virol. 89, 9765\u20139780 (2015).","journal-title":"J. Virol."},{"key":"1327_CR239","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1128\/JVI.01369-06","volume":"80","author":"CS Adamson","year":"2006","unstructured":"Adamson, C. S. et al. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (bevirimat). J. Virol. 80, 10957\u201310971 (2006).","journal-title":"J. Virol."},{"key":"1327_CR240","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1128\/JVI.00493-12","volume":"86","author":"CT Lemke","year":"2012","unstructured":"Lemke, C. T. et al. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. J. Virol. 86, 6643\u20136655 (2012).","journal-title":"J. Virol."},{"key":"1327_CR241","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","volume":"424","author":"B Mangeat","year":"2003","unstructured":"Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99\u2013103 (2003).","journal-title":"Nature"},{"key":"1327_CR242","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1126\/science.1083338","volume":"300","author":"D Lecossier","year":"2003","unstructured":"Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A. J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112 (2003).","journal-title":"Science"},{"key":"1327_CR243","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","volume":"113","author":"RS Harris","year":"2003","unstructured":"Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803\u2013809 (2003).","journal-title":"Cell"},{"key":"1327_CR244","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature01707","volume":"424","author":"H Zhang","year":"2003","unstructured":"Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94\u201398 (2003).","journal-title":"Nature"},{"key":"1327_CR245","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","volume":"114","author":"R Mariani","year":"2003","unstructured":"Mariani, R. et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21\u201331 (2003).","journal-title":"Cell"},{"key":"1327_CR246","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm946","volume":"9","author":"M Marin","year":"2003","unstructured":"Marin, M., Rose, K. M., Kozak, S. L. & Kabat, D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398\u20131403 (2003).","journal-title":"Nat. Med."},{"key":"1327_CR247","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/nm945","volume":"9","author":"AM Sheehy","year":"2003","unstructured":"Sheehy, A. M., Gaddis, N. C. & Malim, M. H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404\u20131407 (2003).","journal-title":"Nat. Med."},{"key":"1327_CR248","doi-asserted-by":"publisher","first-page":"12058","DOI":"10.1128\/JVI.78.21.12058-12061.2004","volume":"78","author":"V Zennou","year":"2004","unstructured":"Zennou, V., Perez-Caballero, D., G\u00f6ttlinger, H. & Bieniasz, P. D. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 78, 12058\u201312061 (2004).","journal-title":"J. Virol."},{"key":"1327_CR249","doi-asserted-by":"publisher","first-page":"13112","DOI":"10.1128\/JVI.00892-07","volume":"81","author":"T Wang","year":"2007","unstructured":"Wang, T. et al. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G. J. Virol. 81, 13112\u201313124 (2007).","journal-title":"J. Virol."},{"key":"1327_CR250","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","volume":"479-480","author":"RS Harris","year":"2015","unstructured":"Harris, R. S. & Dudley, J. P. APOBECs and virus restriction. Virology 479-480, 131\u2013145 (2015).","journal-title":"Virology"},{"key":"1327_CR251","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/microorganisms8121899","volume":"8","author":"WK Xu","year":"2020","unstructured":"Xu, W. K., Byun, H. & Dudley, J. P. The role of APOBECs in viral replication. Microorganisms 8, 1899 (2020).","journal-title":"Microorganisms"},{"key":"1327_CR252","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","volume":"3","author":"N Van Damme","year":"2008","unstructured":"Van Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245\u2013252 (2008).","journal-title":"Cell Host Microbe"},{"key":"1327_CR253","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJD Neil","year":"2008","unstructured":"Neil, S. J. D., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425\u2013430 (2008).","journal-title":"Nature"},{"key":"1327_CR254","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-virology-111821-100816","volume":"10","author":"M Volcic","year":"2023","unstructured":"Volcic, M., Wiesm\u00fcller, L. & Kirchhoff, F. Small but highly versatile: the viral accessory protein Vpu. Annu. Rev. Virol. 10, 243\u2013259 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"1327_CR255","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7398","volume":"7","author":"B Olety","year":"2021","unstructured":"Olety, B., Peters, P., Wu, Y., Usami, Y. & G\u00f6ttlinger, H. HIV-1 propagation is highly dependent on basal levels of the restriction factor BST2. Sci. Adv. 7, eabj7398 (2021).","journal-title":"Sci. Adv."},{"key":"1327_CR256","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1073\/pnas.1321507111","volume":"111","author":"JF Arias","year":"2014","unstructured":"Arias, J. F. et al. Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 111, 6425\u20136430 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000913","volume":"6","author":"JL Douglas","year":"2010","unstructured":"Douglas, J. L. et al. The great escape: viral strategies to counter BST-2\/tetherin. PLoS Pathog. 6, e1000913 (2010).","journal-title":"PLoS Pathog."},{"key":"1327_CR258","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/v11040311","volume":"11","author":"S Beitari","year":"2019","unstructured":"Beitari, S., Wang, Y., Liu, S.-L. & Liang, C. HIV-1 envelope glycoprotein at the interface of host restriction and virus evasion. Viruses 11, 311 (2019).","journal-title":"Viruses"},{"key":"1327_CR259","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","volume":"425","author":"JM Perreira","year":"2013","unstructured":"Perreira, J. M., Chin, C. R., Feeley, E. M. & Brass, A. L. IFITMs restrict the replication of multiple pathogenic viruses. J. Mol. Biol. 425, 4937\u20134955 (2013).","journal-title":"J. Mol. Biol."},{"key":"1327_CR260","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-021-00626-8","volume":"22","author":"S Majdoul","year":"2022","unstructured":"Majdoul, S. & Compton, A. A. Lessons in self-defence: inhibition of virus entry by intrinsic immunity. Nat. Rev. Immunol. 22, 339\u2013352 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1327_CR261","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.celrep.2015.08.055","volume":"13","author":"J Yu","year":"2015","unstructured":"Yu, J. et al. IFITM proteins restrict HIV-1 infection by antagonizing the envelope glycoprotein. Cell Rep. 13, 145\u2013156 (2015).","journal-title":"Cell Rep."},{"key":"1327_CR262","doi-asserted-by":"publisher","first-page":"e03088","DOI":"10.1128\/mBio.03088-19","volume":"11","author":"YS Ahi","year":"2020","unstructured":"Ahi, Y. S. et al. IFITM3 reduces retroviral envelope abundance and function and is counteracted by glycoGag. mBio 11,\u00a0e03088-19 (2020).","journal-title":"mBio"},{"key":"1327_CR263","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41940-0","volume":"14","author":"R Dibsy","year":"2023","unstructured":"Dibsy, R., Bremaud, E., Mak, J., Favard, C. & Muriaux, D. HIV-1 diverts cortical actin for particle assembly and release. Nat. Commun. 14, 6945 (2023).","journal-title":"Nat. Commun."},{"key":"1327_CR264","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407835121","volume":"121","author":"T Serrano","year":"2024","unstructured":"Serrano, T. et al. HIV-1 budding requires cortical actin disassembly by the oxidoreductase MICAL1. Proc. Natl Acad. Sci. USA 121, e2407835121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01327-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:04:25Z","timestamp":1789041865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":264,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01327-6","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"21 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}